GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about General Updates
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GlaxoSmithKline Pharmaceuticals has informed stock exchanges about two upcoming meetings with institutional investors and analysts. On June 20, 2025, the company is meeting Mahindra Manulife AMC in person, followed by a virtual meeting with Aberdeen on June 25, 2025. The company clarified that only information already available in the public domain will be shared during these interactions. The disclosure is filed under SEBI Listing Regulations as a routine regulatory compliance update.
This is a routine disclosure with no new material information, so it is unlikely to have any meaningful impact on the stock price. Shareholders should note that the company is actively engaging with major asset managers, which is a standard investor relations practice.